DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MUCINEX DM

« Back to Dashboard

Clinical Trials for Mucinex Dm

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00441246	Phase 4 Study - Mucinex D as Adjunct Therapy	Completed	Adams Respiratory Therapeutics	Phase 4	The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
NCT00902707	Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung	Completed	Reckitt Benckiser LLC	Phase 1	The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
NCT00902707	Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung	Completed	University of North Carolina, Chapel Hill	Phase 1	The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
NCT01046136	Mucinex Exploratory Cold Study	Completed	Reckitt Benckiser LLC	Phase 2	This is an exploratory, multicenter, randomized, blinded, placebo-controlled study of Mucinex in patients with colds. Patients will receive 7 days of treatment with either Mucinex or placebo. The study will assess the effects of Mucinex on sputum and cold symptoms.

Clinical Trial Conditions for Mucinex Dm

Condition Name

Condition Name for Mucinex Dm
Intervention	Trials
Healthy Subjects	3
Acute Respiratory Infection	2
Mucociliary Clearance	1
Acute Upper Respiratory Track Infection	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Mucinex Dm
Intervention	Trials
Respiratory Tract Infections	4
Infection	3
Communicable Diseases	2
Bronchitis	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Mucinex Dm

Trials by Country

Trials by Country for Mucinex Dm
Location	Trials
United States	46
India	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Mucinex Dm
Location	Trials
North Carolina	4
Massachusetts	3
Nebraska	3
Kentucky	2
Alabama	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Mucinex Dm

Clinical Trial Phase

Clinical Trial Phase for Mucinex Dm
Clinical Trial Phase	Trials
Phase 4	3
Phase 2/Phase 3	1
Phase 2	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Mucinex Dm
Clinical Trial Phase	Trials
Completed	10
Recruiting	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Mucinex Dm

Sponsor Name

Sponsor Name for Mucinex Dm
Sponsor	Trials
Reckitt Benckiser LLC	8
Adams Respiratory Therapeutics	1
Dr. Reddy's Laboratories Limited	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Mucinex Dm
Sponsor	Trials
Industry	10
Other	2

Export unavailable in trial.
Subscribe for complete access.